The increased expression of c-Myc, which is driven by IFN-γ through STAT-3-dependent signaling, has a crucial function in orchestrating a metabolic shift that not only supports tumor proliferation but also reduces the immunogenicity of the tumor, allowing the cancer to avoid detection by the immune system effectively in this model. The gene discussed is STAT3; the disease is cancer.